William Lee Seibel

This inventor holds 13 USPTO granted patents and 2 published patent applications, primarily in Adrenoceptor Agonists. Top assignee: The Procter Gamble Company. Active years: 1992-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Lee Seibel. Retrieved from https://idiyas.com/inventor/william-lee-seibel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 2)

% Patents Active = 92.3

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 124(Granted Patents)

Location History:

Fairfield, OH (US) (1992)
Hamilton, OH (US) (1997 - 2002)

Company Filing History:

13 out of 17,692

The Procter Gamble Company

patents

Years Active: 1992-2002

Loading Chart...

Areas of Expertise:

Adrenoceptor Agonists

Guanidinyl Compounds

Imidazolinyl Compounds

Heterocycles

Antimicrobial Agents

Alpha-2 Agonists

Pharmaceutical Chemistry

Drug Development

Chemical Synthesis

Bioactive Compounds

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6436978 - Guanidinylamino heterocycle compounds useful as &agr;-2 adrenoceptor agonists (2002-08-20),

2. 6395764 - 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agnonists (2002-05-28),

3. 6391878 - Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists (2002-05-21),

4. 6306877 - Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-10-23),

5. 6225331 - Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-05-01),

6. 6172095 - Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-01-09),

7. 6162818 - 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor (2000-12-19),

8. 6110952 - 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor (2000-08-29),

9. 6066740 - Process for making 2-amino-2-imidazoline, guanidine and (2000-05-23),

10. 5965595 - 2-Imidazolinylamino heterocyclic compounds useful as alpha-2 (1999-10-12),

11. 5914342 - 2-imidazolinylamino heterocyclic compounds useful as alpha-2 (1999-06-22),

12. 5663189 - 2-imidazolinylamino heterocyclic compounds useful as alpha-2 (1997-09-02),

13. 5096700 - Halogenated aminohexanoates and aminobutyrates antimicrobial agents (1992-03-17),

Title: The Innovative Contributions of William Lee Seibel

Introduction: William Lee Seibel, an accomplished inventor based in Hamilton, OH, has made significant strides in the field of pharmacology through his innovative inventions. With a total of 13 patents to his name, he has contributed valuable compounds that enhance medical treatments.

Latest Patents: Among William's latest patents, two stand out: "Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists" and "2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists." These patents reflect his focus on developing new therapeutic agents that can be instrumental in the medical field.

Career Highlights: William is currently employed at Procter & Gamble Company, a prominent organization known for its innovation-driven culture. His role there has allowed him to push the boundaries of research and development, particularly in pharmacological inventions.

Collaborations: Throughout his career, William has worked alongside talented coworkers, including Russell James Sheldon and Raymond Todd Henry. Their collaboration has undoubtedly fostered a stimulating environment for innovation, driving the development of new ideas and products.

Conclusion: William Lee Seibel's dedication to invention and innovation in the pharmaceutical realm exemplifies the impact an individual can have on improving health outcomes. With his impressive portfolio of patents, he continues to be a pivotal figure in advancing medicinal chemistry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents pending: